<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>enoxaparin</title><link>http://www.unboundmedicine.com/medline/ebm/research/enoxaparin</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19926048/full_citation/Enoxaparin_Versus_Unfractionated_Heparin_in_Elective_Percutaneous_Coronary_Intervention_1_Year_Results_From_the_STEEPLE__SafeTy_and_Efficacy_of_Enoxaparin_in_Percutaneous_coronary_intervention_patients_an_internationaL_randomized_Evaluation__Trial_</link><description>Montalescot G, Gallo R, White HD, et al. <br/><span class="title">Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial. [JOURNAL ARTICLE]</span><br/><span class="source" title="JACC. Cardiovascular interventions">JACC Cardiovasc Interv 2009 Nov; 2(11):1083-1091.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19926048/abstract/Enoxaparin_Versus_Unfractionated_Heparin_in_Elective_Percutaneous_Coronary_Intervention_1_Year_Results_From_the_STEEPLE__SafeTy_and_Efficacy_of_Enoxaparin_in_Percutaneous_coronary_intervention_patients_an_internationaL_randomized_Evaluation__Trial_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19926048/full_citation/Enoxaparin_Versus_Unfractionated_Heparin_in_Elective_Percutaneous_Coronary_Intervention_1_Year_Results_From_the_STEEPLE__SafeTy_and_Efficacy_of_Enoxaparin_in_Percutaneous_coronary_intervention_patients_an_internationaL_randomized_Evaluation__Trial_">Full Citation</a></description></item><item><title>Hepatocyte Growth Factor/Activin A/Follistatin System Activation during Hemodialysis with Different Low Molecular Weight Heparins.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19925286/full_citation/Hepatocyte_Growth_Factor/Activin_A/Follistatin_System_Activation_during_Hemodialysis_with_Different_Low_Molecular_Weight_Heparins_</link><description>Rydzewska-Rosołowska A, Borawski J, Myśliwiec M <br/><span class="title">Hepatocyte Growth Factor/Activin A/Follistatin System Activation during Hemodialysis with Different Low Molecular Weight Heparins. [JOURNAL ARTICLE]</span><br/><span class="source" title="Renal failure">Ren Fail 2009 Jan; 31(9):791-797.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19925286/abstract/Hepatocyte_Growth_Factor/Activin_A/Follistatin_System_Activation_during_Hemodialysis_with_Different_Low_Molecular_Weight_Heparins_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19925286/full_citation/Hepatocyte_Growth_Factor/Activin_A/Follistatin_System_Activation_during_Hemodialysis_with_Different_Low_Molecular_Weight_Heparins_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19925286/Hepatocyte_Growth_Factor/Activin_A/Follistatin_System_Activation_during_Hemodialysis_with_Different_Low_Molecular_Weight_Heparins_">Find Related Articles</a> </description></item><item><title>Rivaroxaban, the first oral, direct factor Xa inhibitor.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19925048/full_citation/Rivaroxaban_the_first_oral_direct_factor_Xa_inhibitor_</link><description>Fassiadis N <br/><span class="title">Rivaroxaban, the first oral, direct factor Xa inhibitor. [JOURNAL ARTICLE]</span><br/><span class="source" title="Expert opinion on pharmacotherapy">Expert Opin Pharmacother 2009 Nov 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19925048/abstract/Rivaroxaban_the_first_oral_direct_factor_Xa_inhibitor_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19925048/full_citation/Rivaroxaban_the_first_oral_direct_factor_Xa_inhibitor_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19925048/Rivaroxaban_the_first_oral_direct_factor_Xa_inhibitor_">Find Related Articles</a> </description></item><item><title>Apixaban or Enoxaparin for Thromboprophylaxis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19923583/full_citation/Apixaban_or_Enoxaparin_for_Thromboprophylaxis_</link><description>Gómez-Outes A, Suárez-Gea ML, Pozo-Hernández C, et al. <br/><span class="title">Apixaban or Enoxaparin for Thromboprophylaxis. [JOURNAL ARTICLE]</span><br/><span class="source" title="The New England journal of medicine">N Engl J Med 2009 Nov 19; 361(21):2100-2101.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19923583/full_citation/Apixaban_or_Enoxaparin_for_Thromboprophylaxis_">Full Citation</a> | <a href="http://content.nejm.org/cgi/pmidlookup%3fview=short%26amp;pmid=19923583%26amp;promo=ONFLNS19">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19923583/Apixaban_or_Enoxaparin_for_Thromboprophylaxis_">Find Related Articles</a> </description></item><item><title>Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: Results from a multicenter, randomized, open-label study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19919878/full_citation/Efficacy_and_safety_of_enoxaparin_in_Japanese_patients_undergoing_curative_abdominal_or_pelvic_cancer_surgery:_Results_from_a_multicenter_randomized_open_label_study_</link><description>Sakon M <br/><span class="title">Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: Results from a multicenter, randomized, open-label study. [JOURNAL ARTICLE]</span><br/><span class="source" title="Thrombosis research">Thromb Res 2009 Nov 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19919878/abstract/Efficacy_and_safety_of_enoxaparin_in_Japanese_patients_undergoing_curative_abdominal_or_pelvic_cancer_surgery:_Results_from_a_multicenter_randomized_open_label_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19919878/full_citation/Efficacy_and_safety_of_enoxaparin_in_Japanese_patients_undergoing_curative_abdominal_or_pelvic_cancer_surgery:_Results_from_a_multicenter_randomized_open_label_study_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19919878/Efficacy_and_safety_of_enoxaparin_in_Japanese_patients_undergoing_curative_abdominal_or_pelvic_cancer_surgery:_Results_from_a_multicenter_randomized_open_label_study_">Find Related Articles</a> </description></item><item><title>Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19916994/full_citation/Modelling_the_occurrence_and_severity_of_enoxaparin_induced_bleeding_and_bruising_events_</link><description>Barras MA, Duffull SB, Atherton JJ, et al. <br/><span class="title">Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="British journal of clinical pharmacology">Br J Clin Pharmacol 2009 Nov; 68(5):700-11.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19916994/abstract/Modelling_the_occurrence_and_severity_of_enoxaparin_induced_bleeding_and_bruising_events_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19916994/full_citation/Modelling_the_occurrence_and_severity_of_enoxaparin_induced_bleeding_and_bruising_events_">Full Citation</a> | <a href="http://www3.interscience.wiley.com/resolve/openurl%3fgenre=article%26amp;sid=nlm:pubmed%26amp;issn=0306-5251%26amp;date=2009%26amp;volume=68%26amp;issue=5%26amp;spage=700">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19916994/Modelling_the_occurrence_and_severity_of_enoxaparin_induced_bleeding_and_bruising_events_">Find Related Articles</a> </description></item><item><title>Antithrombotic Effect of Enoxaparin in Clinically Healthy Cats: A Venous Stasis Model.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19912519/full_citation/Antithrombotic_Effect_of_Enoxaparin_in_Clinically_Healthy_Cats:_A_Venous_Stasis_Model_</link><description>Van De Wiele CM, Hogan DF, Green HW, et al. <br/><span class="title">Antithrombotic Effect of Enoxaparin in Clinically Healthy Cats: A Venous Stasis Model. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of veterinary internal medicine / American College of Veterinary Internal Medicine">J Vet Intern Med 2009 Nov 11.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19912519/abstract/Antithrombotic_Effect_of_Enoxaparin_in_Clinically_Healthy_Cats:_A_Venous_Stasis_Model_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19912519/full_citation/Antithrombotic_Effect_of_Enoxaparin_in_Clinically_Healthy_Cats:_A_Venous_Stasis_Model_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19912519/Antithrombotic_Effect_of_Enoxaparin_in_Clinically_Healthy_Cats:_A_Venous_Stasis_Model_">Find Related Articles</a> </description></item><item><title>[Rivaroxaban (Xarelto): new anticoagulant inhibitor of factor Xa]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19911670/full_citation/[Rivaroxaban__Xarelto_:_new_anticoagulant_inhibitor_of_factor_Xa]</link><description>Scheen AJ <br/><span class="title">[Rivaroxaban (Xarelto): new anticoagulant inhibitor of factor Xa] [English Abstract, Journal Article]</span><br/><span class="source" title="Revue médicale de Liège">Rev Med Liege 2009 Oct; 64(10):538-43.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19911670/abstract/[Rivaroxaban__Xarelto_:_new_anticoagulant_inhibitor_of_factor_Xa]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19911670/full_citation/[Rivaroxaban__Xarelto_:_new_anticoagulant_inhibitor_of_factor_Xa]">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19911670/[Rivaroxaban__Xarelto_:_new_anticoagulant_inhibitor_of_factor_Xa]">Find Related Articles</a> </description></item><item><title>Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip and knee surgery: a single technology appraisal.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19804690/full_citation/Dabigatran_etexilate_for_the_prevention_of_venous_thromboembolism_in_patients_undergoing_elective_hip_and_knee_surgery:_a_single_technology_appraisal_</link><description>Holmes M, Carroll C, Papaioannou D <br/><span class="title">Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip and knee surgery: a single technology appraisal. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Health technology assessment (Winchester, England)">Health Technol Assess 2009 Sep.:55-62.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19804690/abstract/Dabigatran_etexilate_for_the_prevention_of_venous_thromboembolism_in_patients_undergoing_elective_hip_and_knee_surgery:_a_single_technology_appraisal_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19804690/full_citation/Dabigatran_etexilate_for_the_prevention_of_venous_thromboembolism_in_patients_undergoing_elective_hip_and_knee_surgery:_a_single_technology_appraisal_">Full Citation</a></description></item><item><title>[Dabigatran (Pradaxa): efficacy and safety]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19875000/full_citation/[Dabigatran__Pradaxa_:_efficacy_and_safety]</link><description>Rosencher N, Bellamy L <br/><span class="title">[Dabigatran (Pradaxa): efficacy and safety] [English Abstract, Journal Article]</span><br/><span class="source" title="Annales françaises d'anesthèsie et de rèanimation">Ann Fr Anesth Reanim 2009 Sep; 28(9 Suppl):S15-22.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19875000/abstract/[Dabigatran__Pradaxa_:_efficacy_and_safety]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19875000/full_citation/[Dabigatran__Pradaxa_:_efficacy_and_safety]">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19875000/[Dabigatran__Pradaxa_:_efficacy_and_safety]">Find Related Articles</a> </description></item></channel></rss>